Search Results "#Immunotherapy"

Blogs

arrow_forward View More Results
Biosimilar Monoclonal Antibodies Market: How Is mAb Biosimilar Innovation Creating Affordable Biologic Therapy Infrastructure?
Posted by Surbhi on July 18 2026 at 03:01 PM   public
Monoclonal antibody biosimilar innovation creating infrastructure — biosimilar mAbs providing more affordable versions of approved biologics enabling broader therapeutic access for cancer, immuno...
Tildrakizumab Market: How Is IL-23 Inhibition Innovation Creating Psoriasis Treatment Infrastructure?
Posted by Surbhi on July 17 2026 at 01:57 PM   public
IL-23 inhibition innovation creating infrastructure — tildrakizumab targeting interleukin-23 reducing psoriasis and related inflammatory diseases through selective immune modulation, establishing...
Bladder Cancer Immunotherapy Market Growth to Push Value to USD 29.75 Billion by 2036
Posted by Alexa morgan on September 19 2026 at 12:59 PM   public
The global bladder cancer immunotherapy market is projected to reach USD 29.75 billion by 2036, rising from USD 11.44 billion in 2026 at a 10.0% CAGR, according to Fact.MR analysis. The market is...
Global Dendritic Cell Cancer Vaccine Market Expanding at 12.3% CAGR
Posted by naznins407 on March 10 2026 at 05:09 PM   public
Rising global cancer cases are driving the demand for more effective treatment options. Dendritic cell vaccines offer a personalized approach to cancer therapy. This growing need for targeted tre...
Cancer Immunotherapy Market to See Steady Growth by 2030
Posted by lameyan201@ampdial.com on November 12 2025 at 05:39 PM   public
MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Cancer Immunotherapy Market Research Report: Forecast (2025–2030). This repo...
arrow_forward